Tag Archives: AVID

Hot Small Cap Stocks To Buy For 2018

The Q4 2016 earnings report forsmall cap Yelp Inc (NYSE: YELP) is scheduled forafter the market closes onThursday (February 9). Yelp Inc was last inour SmallCap Network Elite Opportunity (SCN EO) portfolioin August 2015with our SCN EO newsletterhaving this to say:

There’s no question YELP has recently fallen out of Wall Street favor, but if you consider they’re the still the biggest....More>>>

private investors

TripAdvisor (TRIP) tumbled to the bottom of the S&P 500 today, a reversal of yesterday’s big gain following the news thatExpedia (EXPE) would participate in its Instant Booking program.

Agence France-Presse/Getty Images

TripAdvisordropped 5.1% to $46.28 today, while the S&P 500 declined 0.3% to 2,265.18.

In a note published yesterday, SunTrust Robinson Humphrey’s....More>>>

Top 10 Undervalued Stocks To Own Right Now

I came across NetEase (NASDAQ:NTES) in early 2013, when it was starting to become a major player in the Chinese mobile game industry. At first, I was a bit skeptical about their future growth and valuation. Video game companies are sometimes “one-hit wonders”, and decline after their top sellers lose popularity. But NetEase is an exception. After watching it for a few months, I decided....More>>>

Top 5 Clean Energy Stocks To Watch For 2018

The news out of Denver just keeps getting better and better. SPYR, Inc. (OTC: SPYR) the Denver based mobile game & app development and publishing company, today announced that its wholly owned subsidiary, SPYR APPS, LLC, has acquired all assets related to the game Battlewack: Idle Lords.

Battlewack: Idle Lords is a free-to-play battle game in which players hire....More>>>

us stock market holidays

24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly results this week. A little more than one-third of the companies in the Dow are reporting this coming week. Although the Dow has backed off its highs, a strong earnings showing from these companies could push the index higher again.

We have included the consensus earnings....More>>>

Top 5 Low Price Stocks To Buy Right Now

In my very first MannKind article I offered for my SA readers, I made the following statement:

Wall Street gurus are always smarter than the retail investor that doesn’t do their homework.

I have mentioned several times that MannKind’s (NASDAQ:MNKD) management understands the reality and has done a remarkable job in keeping the company hooked up to a life support system....More>>>

stock prices

The Federal Reserve raised its target of the federal-funds rate, the interest rate banks charge each other for overnight loans, by a quarter point to a range of 0.75% to 1%, and thats great news for Warren Buffetts Berkshire Hathaway (BRK.B) and its shareholders. As a bondholder, owner of insurance companies and an investor in big banks, Berkshire profits from rising interest rates in a number....More>>>

Top Bank Stocks To Watch For 2017

Okay, time for some secular economic and financial heresy, which is always somewhat fun. Secondary market liquidity isn’t very important to the functioning of the general economy of the capitalist world, including the US. (That said, my exceptions to this statement are listed here.)

Finance has an important role in the economy, aiding business in financing the assets of the corporation,....More>>>

Hot Heal Care Stocks To Buy Right Now

Source: ThinkstockSolar energy adoption among large U.S. corporations has grown from a total installed base of 300 megawatts (MW) in 2012 to more than 1,000 MW this year. The total represents 16% of all non-residential and non-utility scale solar photovoltaic (PV) capacity in the country. Collectively these systems generate 1.5 million MWs a year, enough to power 193,000 homes and offset 1.1 million....More>>>

stock valuation

On August 30, the Food and Drug Administration (FDA) approved Novartis’ (NYSE:NVS) Erelzi, a biosimilar to Amgen’s (NASDAQ:AMGN) biggest seller, Enbrel. Erelzi is the second biosimilar available in the U.S. after Zarxio, also by Novartis, and again a biosimilar to another of Amgen’s top products, Neupogen. Amgen has been trying its best to offset these challenges by advancing new....More>>>